Accuracy of the pacemaker-mediated tachycardia algorithm in Boston Scientific devices.

Area of Science:

• Cardiology
• Biomedical Engineering
• Medical Device Technology

Background:

• Pacemaker-mediated tachycardia (PMT) incidence is influenced by patient factors, device programming, and algorithm specifics.
• Investigating the efficacy of specific algorithms is crucial for optimizing pacemaker function and patient outcomes.

Purpose of the Study:

• To evaluate the diagnostic accuracy and clinical implications of the Boston Scientific RYTHMIQ™ algorithm in managing pacemaker-mediated tachycardia (PMT).

Main Methods:

• A multicenter study reviewed 784 PMT episodes from 118 patients with Boston Scientific devices.
• Patients were categorized into RYTHMIQ™ activated, AV-block, and Cardiac Resynchronization Therapy (CRT) groups.
• Remote monitoring-transmitted electrograms (EGMs) were analyzed for PMT diagnosis accuracy.

Main Results:

• The RYTHMIQ™ algorithm correctly diagnosed PMT in 80% of episodes, often linked to AV-delay prolongation.
• Incorrect PMT diagnoses occurred in 20% of RYTHMIQ™ patients and most AV-block (66%) and CRT (74%) patients during sinus tachycardia.
• Inappropriate algorithm interventions during exercise led to non-conducted P-waves, loss of CRT in six patients, and a potential pro-arrhythmic event in one patient.

Conclusions:

• Boston Scientific's PMT algorithm demonstrates high accuracy but is prone to misdiagnosis during exercise.
• Incorrect diagnoses can result in inappropriate therapies, including loss of CRT and potential pro-arrhythmic effects.
• Algorithm refinement is needed to minimize unintended consequences and improve patient safety.